Health Canada approves Lipocine's TLANDO capsules for testosterone replacement therapy

Health Canada has approved TLANDO capsules, developed by Lipocine's licensing partner Verity Pharmaceuticals, for testosterone replacement therapy in adult males.

Detected & updated continuously · Source: Nebula

Story subjects

Lipocine Inc.Health Canada

Track sentiment and mindshare across stocks and crypto in Nebula.

Open Nebula